Indietro

Selezionare la regione

Azienda

Richiedi un consulto sulle cellule staminali

Per saperne di più

I nostri
trapianti

Elenco degli utilizzi delle cellule staminali approvati dai laboratori del gruppo FamiCord:

Immagine
Elenco degli utilizzi delle cellule staminali approvati dai laboratori del gruppo FamiCord:
Nr. Fonte Tipo di fonte Diagnosi Settore medico Anno di applicazione Terapia Paese Età del destinatario
101 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Germany 63
102 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Netherlands 47
103 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Czechia 67
104 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Sweden 74
105 Bone Marrow Family Allogeneic Non-Hodgkin Lymphoma Hematology 2026 Standard Therapy Germany 72
106 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Ukraine 40
107 Bone Marrow Family Allogeneic No Data Hematology 2026 Standard Therapy Germany 70
108 Bone Marrow Family Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy Hungary 35
109 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 71
110 Bone Marrow Family Allogeneic Primary Myelofibrosis Hematology 2026 Standard Therapy Poland 37
111 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy France 68
112 Bone Marrow Family Allogeneic Fanconi Anemia Hematology 2026 Standard Therapy Germany 4
113 Bone Marrow Family Allogeneic Acute Myeloid Leukemia (Relapse) Hematology 2026 Standard Therapy Germany 66
114 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Germany 70
115 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy France 42
116 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Netherlands 57
117 Bone Marrow Family Allogeneic Polycythaemia Vera Hematology 2026 Standard Therapy Germany 61
118 Bone Marrow Family Allogeneic CMML – Beginning Relapse Hematology 2026 Standard Therapy Netherlands 63
119 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Australia 64
120 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 76
121 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Switzerland 66
122 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Finland 40
123 Bone Marrow Family Allogeneic T-Cell Prolymphocytic Leukemia Hematology 2026 Standard Therapy Norway 64
124 Bone Marrow Family Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy Spain 47
125 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 66
126 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Czechia 68
127 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Poland 26
128 Bone Marrow Family Allogeneic Acute Myeloid Leukemia hematology 2026 Standard Therapy Germany 67
129 Bone Marrow Family Allogeneic Acute Myeloid Leukemia hematology 2026 Standard Therapy Germany 51
130 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy France 67
131 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy USA 30
132 Bone Marrow Family Allogeneic Acute Lymphoblastic Leukemia hematology 2026 Standard Therapy Hungary 10
133 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Germany 63
134 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia / MDR Relapse hematology 2026 Standard Therapy Ukraine 39
135 Bone Marrow Family Allogeneic Chronic Myelomonocytic Leukemia hematology 2026 Standard Therapy USA 70
136 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Poland 72
137 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard therapy USA 76
138 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard therapy USA 72
139 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Germany 3
140 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Hungary 62
141 Bone Marrow Allogeneic Fanconi Anemia Hematology 2026 Standard Therapy Austria 7
142 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Belgium 12
143 Bone Marrow Allogeneic Combined Immunodeficiency Hematology 2026 Standard Therapy Belgia 3
144 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Italy 60
145 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy Italy 7
146 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy Italy 4
147 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Germany 8
148 Bone Marrow Allogeneic Other Immune System Hematology 2026 Standard Therapy USA 5
149 Bone Marrow Allogeneic Adrenoleukodystrophy (X-ALD) Hematology 2026 Standard Therapy Czechia 5
150 Bone Marrow Allogeneic Wiskott-Aldrich Syndrome Hematology 2026 Standard Therapy Germany 19
151 Bone Marrow Allogeneic Wiskott-Aldrich Syndrome Hematology 2026 Standard Therapy USA 11
152 Bone Marrow Allogeneic Serum Amyloid A (SAA) Hematology 2026 Standard Therapy Austria 16
153 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2026 Standard Therapy France 32
154 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2026 Standard Therapy Germany 16
155 Bone Marrow Allogeneic Other Malignancy Hematology 2026 Standard Therapy France 5
156 Bone Marrow Allogeneic Mixed type Leukemia Hematology 2026 Standard Therapy Poland 1
157 Bone Marrow Allogeneic OIID, Chronic Granulomatous Disease CGD Hematology 2026 Standard Therapy Germany 2
158 Bone Marrow Allogeneic GATA2 deficiency Hematology 2026 Standard Therapy Belgium 12
159 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Italy 48
160 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 47
161 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy United Kingdom 80
162 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2026 Standard Therapy United Kingdom 15
163 Bone Marrow Allogeneic Severe Aplastic Anemia / AA Amyloidosis Hematology 2026 Standard Therapy United Kingdom 24
164 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Turkey 8
165 Bone Marrow Allogeneic SCID Severe Combined Immunodeficiency Hematology 2026 Standard Therapy Poland 1
166 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2026 Standard Therapy Germany 58
167 Bone Marrow Allogeneic Pure Red Cell Aplasia Hematology 2026 Standard Therapy USA 29
168 Bone Marrow Allogeneic Combined Immunodeficiency Hematology 2026 Standard Therapy USA 19
169 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2026 Standard Therapy France 21
170 Bone Marrow Allogeneic B-thalassemia Hematology 2026 Standard Therapy Netherlands 15
171 Bone Marrow Allogeneic Very Severe Aplastic Anemia Hematology 2026 Standard Therapy Slovakia 31
172 Bone Marrow Allogeneic Hemophagocytic Lymphohistiocytosis Hematology 2026 Standard Therapy Austria 3
173 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 12
174 Bone Marrow Allogeneic Diamond Blackfan Anemia Hematology 2026 Standard Therapy Slovakia 9
175 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Brazil 62
176 Bone Marrow Allogeneic Griscelli syndrome type 2 Hematology 2026 Standard Therapy Canada 39
177 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy France 47
178 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy USA 21
179 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy Hungary 10
180 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 70
181 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy USA 6
182 Bone Marrow Allogeneic Acute Myelogenous Leukemia CR2 Hematology 2026 Standard Therapy Spain 9
183 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy France 7
184 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Hungary 23
185 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2026 Standard Therapy USA 8
186 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2026 Standard Therapy USA 20
187 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 1
188 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2026 Standard Therapy USA 13
189 Bone Marrow Allogeneic Severe Combined Immunodeficiency Hematology 2026 Standard Therapy USA 2 months
190 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2026 Standard Therapy Italy 3
191 Bone Marrow Allogeneic Non-Hodgkin Lymphoma Hematology 2026 Standard Therapy USA 26
192 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Hungary 9
193 Bone Marrow Allogeneic Chronic Myelomonocytic Leukemia Hematology 2026 Standard Therapy Spain 61
194 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Germany 2
195 Bone Marrow Allogeneic Other Leukaemia Hematology 2026 Standard Therapy France 1
196 Bone Marrow Allogeneic – Hematology 2026 Standard Therapy Germany 16
197 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2026 Standard Therapy Belarus 2
198 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy United Kingdom 11
199 Bone Marrow Allogeneic Sickle Cell Disease hematology 2026 Standard Therapy Netherlands 18
200 Bone Marrow Allogeneic Non-Hodgkin Lymphoma hematology 2026 Standard Therapy Germany 6